Filing Details
- Accession Number:
- 0001556247-13-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-17 16:30:20
- Reporting Period:
- 2013-01-16
- Filing Date:
- 2013-01-17
- Accepted Time:
- 2013-01-17 16:30:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Finance And Admin Cfo Trea | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-01-16 | 2,051 | $170.57 | 64,419 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-01-16 | 1,200 | $171.11 | 63,219 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-01-16 | 2,200 | $172.77 | 61,019 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-01-16 | 2,227 | $173.37 | 58,792 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-01-16 | 200 | $174.56 | 58,592 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,560 | Indirect | By 401(k) Plan |
Common Stock | 750 | Indirect | by Spouse |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 2,051 shares of Company stock on January 16, 2013 at prices ranging from $170.31 to $170.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 16, 2013 at each separate price.
- Represents volume-weighted average price of sales of 1,200 shares of Company stock on January 16, 2013 at prices ranging from $171.00 to $171.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 16, 2013 at each separate price.
- Represents volume-weighted average price of sales of 2,200 shares of Company stock on January 16, 2013 at prices ranging from $172.03 to $172.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 16, 2013 at each separate price.
- Represents volume-weighted average price of sales of 2,227 shares of Company stock on January 16, 2013 at prices ranging from $173.01 to $173.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 16, 2013 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on January 16, 2013 at prices ranging from $174.27 to $174.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 16, 2013 at each separate price.